Orgenesis GAAP EPS of -0.29, revenue of 0.14M
| ORGSDelisted Stock | USD 1.22 0.31 20.26% |
Slightly above 64% of Orgenesis' investor base is looking to short. The analysis of overall sentiment of trading Orgenesis otc stock suggests that many investors are alarmed at this time. Orgenesis' investing sentiment can be driven by a variety of factors including economic data, Orgenesis' earnings reports, geopolitical events, and overall market trends.
Orgenesis otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Orgenesis daily returns and investor perception about the current price of Orgenesis as well as its diversification or hedging effects on your existing portfolios.
Orgenesis |
Orgenesis releases Q1 results GAAP EPS of -0.29 and revenue of 0.14M, showing no growth YoY.
Read at seekingalpha.com
 |
Orgenesis Fundamental Analysis
We analyze Orgenesis' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orgenesis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orgenesis based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Orgenesis is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Orgenesis Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Orgenesis otc stock to make a market-neutral strategy. Peer analysis of Orgenesis could also be used in its relative valuation, which is a method of valuing Orgenesis by comparing valuation metrics with similar companies.
Peers
Orgenesis Related Equities
| DSGN | Design Therapeutics | 4.34 | ||||
| RZLT | Rezolute | 3.78 | ||||
| ADAG | Adagene | 1.99 | ||||
| LIXT | Lixte Biotechnology | 1.52 | ||||
| ACRV | Acrivon Therapeutics, | 0.30 | ||||
| ACHL | Achilles Therapeutics | 0.10 | ||||
| TNGX | Tango Therapeutics | 0.00 | ||||
| QNRX | Quoin Pharmaceuticals | 0.18 | ||||
| INDP | Indaptus Therapeutics | 0.21 | ||||
| ANTX | AN2 Therapeutics | 0.79 | ||||
| AVTE | Aerovate Therapeutics | 1.17 | ||||
| KTTA | Pasithea Therapeutics | 1.50 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price. Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Orgenesis OTC Stock
If you are still planning to invest in Orgenesis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orgenesis' history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |